Miller CL

ORCID: 0000-0003-4276-3607 · 2 papers in corpus

meta-analysis 2023

Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization

Arthritis & rheumatology (Hoboken, N.J.) ·doi:10.1002/art.42538

OBJECTIVE: In this study, we aimed to establish the causal effects of lowering sclerostin, target of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors. METHODS: A genome-wide association study meta-analysis was…

observational 1982

Prognosis of pulmonary scar carcinoma

The Journal of thoracic and cardiovascular surgery ·doi:10.1016/s0022-5223(19)39004-x

Eighty-one patients with resectable primary peripheral lung carcinomas were studied to determine the effect of associated scarring on prognosis. Twelve tumors (15%) originated from bronchi. 24 (30%) were associated with scars, and 45 (55%) …